Why Ginkgo Bioworks Stock Blasted 7% Higher Today

Cutting-edge biotech company Ginkgo Bioworks Holdings (NYSE: DNA) was a popular stock on Tuesday. The cell engineering specialist's share price zoomed more than 7% higher today, thanks to quarterly results that greatly pleased investors. Interestingly, Ginkgo actually missed widely on earnings.